A detailed history of Fifth Third Bancorp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 804 shares of NBIX stock, worth $100,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares
804
Previous 716 12.29%
Holding current value
$100,910
Previous $98,000 6.12%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$114.58 - $153.15 $10,083 - $13,477
88 Added 12.29%
804 $92,000
Q2 2024

Jul 22, 2024

BUY
$130.86 - $143.19 $12,039 - $13,173
92 Added 14.74%
716 $98,000
Q1 2024

Apr 23, 2024

BUY
$130.4 - $143.74 $4,172 - $4,599
32 Added 5.41%
624 $86,000
Q4 2023

Jan 19, 2024

SELL
$106.07 - $132.76 $3,182 - $3,982
-30 Reduced 4.82%
592 $78,000
Q3 2023

Oct 31, 2023

BUY
$94.02 - $117.1 $19,838 - $24,708
211 Added 51.34%
622 $69,000
Q2 2023

Jul 25, 2023

BUY
$89.53 - $104.87 $5,550 - $6,501
62 Added 17.77%
411 $38,000
Q1 2023

Apr 24, 2023

BUY
$94.11 - $123.02 $4,517 - $5,904
48 Added 15.95%
349 $35,000
Q4 2022

Jan 25, 2023

SELL
$106.72 - $127.06 $1,600 - $1,905
-15 Reduced 4.75%
301 $0
Q3 2022

Oct 25, 2022

SELL
$92.03 - $107.81 $9,479 - $11,104
-103 Reduced 24.58%
316 $34,000
Q2 2022

Aug 04, 2022

BUY
$75.79 - $100.07 $7,730 - $10,207
102 Added 32.18%
419 $41,000
Q1 2022

Apr 19, 2022

BUY
$72.45 - $94.81 $4,999 - $6,541
69 Added 27.82%
317 $30,000
Q3 2021

Oct 15, 2021

BUY
$86.18 - $99.03 $20,510 - $23,569
238 Added 2380.0%
248 $24,000
Q2 2021

Aug 06, 2021

BUY
$89.43 - $102.27 $894 - $1,022
10 New
10 $1,000
Q2 2020

Aug 05, 2020

SELL
$85.09 - $130.36 $8,849 - $13,557
-104 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$75.11 - $113.76 $1,351 - $2,047
-18 Reduced 14.75%
104 $9,000
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $1,562 - $2,134
18 Added 17.31%
122 $13,000
Q3 2019

Nov 14, 2019

SELL
$83.82 - $101.5 $75,102 - $90,944
-896 Reduced 89.6%
104 $9,000
Q1 2019

May 14, 2019

BUY
$69.31 - $91.53 $69,240 - $91,438
999 Added 99900.0%
1,000 $88,000
Q4 2018

Feb 14, 2019

SELL
$68.32 - $124.36 $6,012 - $10,943
-88 Reduced 98.88%
1 $0
Q3 2018

Nov 14, 2018

SELL
$98.88 - $125.85 $7,613 - $9,690
-77 Reduced 46.39%
89 $11,000
Q1 2018

May 15, 2018

SELL
$75.88 - $92.43 $13,354 - $16,267
-176 Reduced 51.46%
166 $14,000
Q4 2017

Feb 14, 2018

SELL
$58.53 - $77.59 $22,943 - $30,415
-392 Reduced 53.41%
342 $27,000
Q3 2017

Nov 14, 2017

SELL
$47.97 - $61.28 $10,793 - $13,788
-225 Reduced 23.46%
734 $45,000
Q2 2017

Aug 11, 2017

BUY
N/A
959
959 $44,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.